Sunshine Biopharma (SBFM) Cost of Revenue (2018 - 2026)
Sunshine Biopharma (SBFM) reported Cost of Revenue of $6.84 million for Q2 2026, up 14.2% from $5.99 million a year earlier and up 15.7% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Cost of Revenue (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Sunshine Biopharma's Cost of Revenue came in at $24.64 million, up 1.7% year-over-year; for FY2025, it was $24.05 million, down 0.6% from FY2024.
- Cost of Revenue has a five-year compound annual growth rate of 292.4% (FY2020 to FY2025).
- By year, Cost of Revenue came in at $24.2 million in FY2024 (+53.6%), $15.75 million in FY2023 (+494.7%), $2.65 million in FY2022 and $117,830 in FY2021 (+355.9%).
- The Q2 2026 figure ranks as the highest quarterly Cost of Revenue since Q2 2024.
- Year over year, Cost of Revenue gained in five of the last eight quarters, with growth averaging 10.2%.
- The high point for year-over-year Cost of Revenue in five years was Q4 2021 (growth of 485.8%); the low point was Q4 2025 (a decline of 14.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.91 million (Q1 2026), $5.55 million (Q4 2025) and $6.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Sunshine Biopharma | 914,767.10 | -38.18 Mn | 2.43 Mn | 6.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.84 Mn |
| Mar 31, 2026 | 5.91 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 6.34 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 6.17 Mn |
| Dec 31, 2024 | 6.50 Mn |
| Sep 30, 2024 | 5.57 Mn |
| Jun 30, 2024 | 6.95 Mn |
| Mar 31, 2024 | 5.19 Mn |
| Dec 31, 2023 | 5.11 Mn |
| Sep 30, 2023 | 3.97 Mn |
| Jun 30, 2023 | 3.61 Mn |
| Mar 31, 2023 | 3.07 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 65,783.00 |
| Jun 30, 2022 | 74,683.00 |
| Mar 31, 2022 | 59,845.00 |
| Dec 31, 2021 | 61,289.00 |
| Sep 30, 2021 | 19,506.00 |
API Access
Sunshine Biopharma Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();